Skip to main content

MoneyWorks4Me

Cipla informs about acquisition

06 Jan 2024 Evaluate
Cipla has informed that Cipla (EU), wholly owned subsidiary of the Company in UK, has entered into a joint venture agreement with Kemwell Biopharma UK and MNI Ventures, Mauritius on 5th January, 2024 for incorporation of a joint venture company in USA.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..